Yaming Hang

3.4k total citations
17 papers, 195 citations indexed

About

Yaming Hang is a scholar working on Cognitive Neuroscience, Experimental and Cognitive Psychology and Oncology. According to data from OpenAlex, Yaming Hang has authored 17 papers receiving a total of 195 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cognitive Neuroscience, 4 papers in Experimental and Cognitive Psychology and 3 papers in Oncology. Recurrent topics in Yaming Hang's work include Sleep and related disorders (4 papers), Sleep and Wakefulness Research (4 papers) and Multiple Sclerosis Research Studies (2 papers). Yaming Hang is often cited by papers focused on Sleep and related disorders (4 papers), Sleep and Wakefulness Research (4 papers) and Multiple Sclerosis Research Studies (2 papers). Yaming Hang collaborates with scholars based in United States, United Kingdom and Egypt. Yaming Hang's co-authors include Joseph J. Eron, Bach‐Yen Nguyen, Havilland Campbell, Wen‐Lin Luo, Larissa Wenning, Peter Sklar, Matthew L. Rizk, Jing Su, Jing Zhao and Ahmed A. Othman and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Anesthesiology and Journal of Affective Disorders.

In The Last Decade

Yaming Hang

17 papers receiving 191 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yaming Hang United States 7 72 52 37 29 26 17 195
R Rescaldani Italy 11 91 1.3× 21 0.4× 48 1.3× 6 0.2× 102 3.9× 24 419
J. Sorbel United States 16 185 2.6× 23 0.4× 95 2.6× 26 0.9× 14 0.5× 50 1.1k
Lawrence K. Oliver United States 9 66 0.9× 51 1.0× 51 1.4× 83 2.9× 7 0.3× 11 304
Mohammad Bsharat United States 6 206 2.9× 7 0.1× 24 0.6× 66 2.3× 8 0.3× 10 803
Parul Gupta India 10 177 2.5× 167 3.2× 92 2.5× 11 0.4× 19 0.7× 39 442
Lien Gheyle United States 8 26 0.4× 4 0.1× 51 1.4× 9 0.3× 90 3.5× 19 283
Yun Zhu Bai United States 7 19 0.3× 17 0.3× 43 1.2× 31 1.1× 31 1.2× 17 307
Jasmini Alagaratnam United Kingdom 9 119 1.7× 89 1.7× 25 0.7× 8 0.3× 6 0.2× 23 270
M. Raptopoulou Greece 11 41 0.6× 9 0.2× 15 0.4× 31 1.1× 12 0.5× 22 327

Countries citing papers authored by Yaming Hang

Since Specialization
Citations

This map shows the geographic impact of Yaming Hang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yaming Hang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yaming Hang more than expected).

Fields of papers citing papers by Yaming Hang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yaming Hang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yaming Hang. The network helps show where Yaming Hang may publish in the future.

Co-authorship network of co-authors of Yaming Hang

This figure shows the co-authorship network connecting the top 25 collaborators of Yaming Hang. A scholar is included among the top collaborators of Yaming Hang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yaming Hang. Yaming Hang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Hang, Yaming, et al.. (2025). Tracing two decades: Non-linear temporal trends in mental health among Chinese university students (2005–2024). Journal of Affective Disorders. 393(Pt A). 120341–120341. 1 indexed citations
2.
Guzy, Serge, Tomoki Yoneyama, Sergio Iadevaia, et al.. (2025). Establishment of a Biomarker‐Directed Clinical Endpoint Model for Early‐Stage Parkinson's Disease Patients. Clinical Pharmacology & Therapeutics. 117(5). 1460–1469. 2 indexed citations
3.
Dahan, Albert, Yaming Hang, Hong Lu, et al.. (2025). TAK-925 (Danavorexton), an Orexin Receptor 2 Agonist, Reduces Opioid-induced Respiratory Depression and Sedation without Affecting Analgesia in Healthy Men. Anesthesiology. 142(4). 628–638. 2 indexed citations
4.
Linninger, Andreas A., Dipak Barua, Yaming Hang, Sergio Iadevaia, & Majid Vakilynejad. (2023). A mechanistic pharmacokinetic model for intrathecal administration of antisense oligonucleotides. Frontiers in Physiology. 14. 1130925–1130925. 8 indexed citations
5.
Goteti, Kosalaram, Mindy Magee, Sven Mensing, et al.. (2023). Opportunities and Challenges of Disease Progression Modeling in Drug Development – An IQ Perspective. Clinical Pharmacology & Therapeutics. 114(2). 266–274. 5 indexed citations
6.
Evans, Rebecca, Haruhide Kimura, Masato Nakashima, et al.. (2023). Orexin 2 receptor‐selective agonist danavorexton (TAK‐925) promotes wakefulness in non‐human primates and healthy individuals. Journal of Sleep Research. 32(5). e13878–e13878. 16 indexed citations
7.
Guo, Meilin, Yuan Zhong, Jingren Xu, et al.. (2023). Altered brain function in patients with acrophobia: A voxel-wise degree centrality analysis. Journal of Psychiatric Research. 164. 59–65. 4 indexed citations
8.
Maringwa, John, et al.. (2020). Characterizing Effects of Antidiabetic Drugs on Heart Rate, Systolic and Diastolic Blood Pressure. Clinical Pharmacology & Therapeutics. 109(6). 1583–1592. 15 indexed citations
9.
10.
11.
Bottino, Dean, Yaming Hang, Rachel Neuwirth, et al.. (2019). Abstract A073: Using prebaseline and on-treatment tumor assessments to compare time to tumor size progression of hormonal therapy + sapanisertib vs an extrapolated hormonal therapy alone from a single-arm phase 2 study. Molecular Cancer Therapeutics. 18(12_Supplement). A073–A073. 1 indexed citations
12.
Hu, Xiao, Yaming Hang, Yue Cui, et al.. (2017). Population‐Based Pharmacokinetic and Exposure‐Efficacy Analyses of Peginterferon Beta‐1a in Patients With Relapsing Multiple Sclerosis. The Journal of Clinical Pharmacology. 57(8). 1005–1016. 4 indexed citations
13.
Diao, Lei, Yaming Hang, Ahmed A. Othman, Ivan Nestorov, & Jonathan Q. Tran. (2016). Population Pharmacokinetics of Daclizumab High-Yield Process in Healthy Volunteers and Subjects with Multiple Sclerosis: Analysis of Phase I–III Clinical Trials. Clinical Pharmacokinetics. 55(8). 943–955. 18 indexed citations
14.
Hang, Yaming, Xiao Hu, Jie Zhang, et al.. (2016). Analysis of peginterferon β-1a exposure and Gd-enhanced lesion or T2 lesion response in relapsing-remitting multiple sclerosis patients. Journal of Pharmacokinetics and Pharmacodynamics. 43(4). 371–383. 2 indexed citations
15.
Diao, Lei, Yaming Hang, Ahmed A. Othman, et al.. (2016). Population PK–PD analyses of CD25 occupancy, CD56bright NK cell expansion, and regulatory T cell reduction by daclizumab HYP in subjects with multiple sclerosis. British Journal of Clinical Pharmacology. 82(5). 1333–1342. 14 indexed citations
16.
Rizk, Matthew L., Yaming Hang, Wen‐Lin Luo, et al.. (2012). Pharmacokinetics and Pharmacodynamics of Once-Daily versus Twice-Daily Raltegravir in Treatment-Naïve HIV-Infected Patients. Antimicrobial Agents and Chemotherapy. 56(6). 3101–3106. 77 indexed citations
17.
Potra, Florian A., Françoise Seillier‐Moiseiwitsch, Anindya Roy, et al.. (2006). Protein Image Alignment via Piecewise Affine Transformations. Journal of Computational Biology. 13(3). 614–630. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R Rescaldani Breakdown of academic impact, for papers by J. Sorbel Breakdown of academic impact, for papers by Lawrence K. Oliver Breakdown of academic impact, for papers by Mohammad Bsharat Breakdown of academic impact, for papers by Parul Gupta Breakdown of academic impact, for papers by Lien Gheyle Breakdown of academic impact, for papers by Yun Zhu Bai Breakdown of academic impact, for papers by Jasmini Alagaratnam Breakdown of academic impact, for papers by M. Raptopoulou
Rankless by CCL
2026